nicians consider surgical intervention for VS in patients with refractory symptoms or with large tumors resulting in brainstem compression. Although several studies have evaluated surgical and observational outcomes in the elderly, few have directly compared microsurgical outcomes between elderly and nonelderly groups. 7, 8 Our primary goals were to compare the risks of microsurgical resection in patient groups stratified by age and to test the hypothesis that symptomatic tumors in elderly patients represent a variant of VS that is more aggressive in these patients than in younger adults, resulting in increased morbidity and a higher rate of recurrence after STR.
Methods

Patient Cohorts and Clinical Characteristics
After institutional review board approval, a retrospective chart review was performed, and all patients aged 70 years or older who had undergone microsurgical VS resection between January 2000 and July 2010 at a single tertiary academic referral center were identified. A separate cohort of patients younger than 70 years served as matched controls, and pairing was based on completeness of surgical resection (GTR, NTR, or STR), surgical approach (translabyrinthine, retrosigmoid, or middle fossa), and tumor size (closest match). Patients' clinical, surgical, and radiographic data were obtained. Preoperative tumor size, location, and ipsilateral hearing results were based on the 1995 American Academy of Otolaryngology-Head and Neck Surgery guidelines.
3 Preoperative physical status was assessed using the ASA classification system. 6 Facial nerve function was reported using the House-Brackmann scale preoperatively, immediately postoperatively, at discharge from the hospital, and at last clinical follow-up. 5 Balance function was reported on the basis of in-office clinical evaluation.
Completeness of resection was defined as GTR in cases of complete tumor removal as concluded by both the neurotologist and neurosurgeon, as NTR when a tumor remnant no greater than 5 × 5 × 2 mm was left intentionally to protect neural integrity, and as STR for any operation in which less than NTR was performed. 2 Residual tumor size was defined as the maximum tumor dimension of a nongrowing remnant lesion. The term "recurrent" was defined as progressive enlargement of an enhancing lesion after treatment.
Statistical Analysis
Data from continuous features were summarized as means, SDs, medians, and ranges; categorical data were summarized with frequency counts and percentages. Comparisons of features between patients 70 years or older and their matched controls were evaluated using conditional logistic regression and summarized with ORs and 95% CIs. Recurrence-free and overall survivals were estimated using the Kaplan-Meier method and compared between cases and controls using a log-rank test. The length of follow-up for recurrence-free survival was calculated from the date of surgical intervention to the date of either recurrence or the last clinical visit. The length of follow-up for overall survival was calculated from the date of surgery to either death or the last clinical visit. Statistical analyses were performed using the SAS software package (SAS Institute). All tests were 2 sided, and p values < 0.05 were considered statistically significant.
Results
Demographics
Twenty patients were identified in each group with an average age of 75.9 ± 5.3 years (median 74.5, range 70-86 years) in the elderly group and 55.7 ± 13.8 years (median 60.5, range 25-69 years) in the younger cohort. Elderly patients more commonly had a poorer preoperative physical status or ASA score (p = 0.038) ( Table 1) . No patient had an ASA score of less than 2 based on the presence of a VS. There was no statistically significant difference in tumor size, macrocystic features, or location between the 2 groups. The tumor size was measured as maximum axial dimension (cm), parallel to the petrous bone, excluding the portion within the internal auditory canal. After matching for the extent of the resection and surgical approach, the closest size-matched patient was chosen from the database. Table 1) .
Clinical Presentation
At presentation, subjective symptoms, facial nerve function (p = 0.1), and hearing were similar between the 2 groups ( Table 2 and Fig. 1 ). The most common presenting symptoms included progressive hearing loss, unsteadiness, and hemifacial numbness or tingling. None of the patients presented with facial nerve dysfunction worse than III/VI on the House-Brackmann scale (see preoperative scores in Fig. 1 ). One patient in the elderly group and 5 subjects in the younger adult cohort had serviceable preoperative hearing (OR 5.29, p = 0.13). Patients aged 70 years or older were over 9 times more likely to have reported subjective imbalance or unsteadiness than their matched controls (OR 9.61, p = 0.016). Preoperative physical examination revealed compromised balance and coordination in 17 (85%) of 20 elderly patients and in 10 (50%) of 20 nonelderly patients (OR 9.61, p = 0.016).
Surgical and Perioperative Data
All patients were successfully matched on the basis of the surgical approach used and the extent of the VS resection. The most common reason for both planned and unplanned STR was to preserve facial nerve function. Electrophysiological facial nerve parameters, including the minimal stimulation threshold and percent drop-off for facial nerve response, were not significantly different across the 2 groups. 12 There were also no differences between the 2 groups in length of stay in the neurosurgical intensive care unit and hospital length of stay nor in the frequency of surgical or anesthetic-related complications (Tables 3 and  4) . No patient died in the immediate postoperative period.
One elderly patient died of Clostridium difficile colitis 2 months after surgery. Despite these similarities, elderly patients were statistically significantly more likely to require prolonged physical rehabilitation following acute postoperative care (OR 11.0, p = 0.022) ( Table 4) .
Clinical Outcome
Facial nerve function immediately after surgery, at discharge, and at last follow-up tended to be poorer in the elderly cohort than in the younger cohort, but this trend did not reach significance (Fig. 1) . Patients aged 70 years or older were 13 times more likely to have prolonged postoperative imbalance than their matched controls (OR 13.00, p = 0.013). There were no additional differences between the 2 groups in the symptoms or examination findings at the last follow-up (Table 5) .
In each cohort, 4 patients underwent GTR and 16 received STR: in 11 a retrosigmoid approach was used and 9 underwent translabyrinthine resection. The length of clinical and radiographic follow-up was very similar between the 2 cohorts. No VS recurred after GTR. There was no difference in residual tumor size after STR between the elderly and control groups. In both groups combined, 9 tumors showed progressive growth following STR (Table 6 ). In the older group, 6 tumors recurred at a median time period of 2.9 years after surgery (range 1.4-5.5 years). Three of the 20 controls showed tumor recurrence at a median of 2.3 years (range: 2.3-2.6 years) after surgery. Among the remaining 31 cases who did not show tumor recurrence, the mean length of time from surgery to the last clinical visit was 2.7 years (median 2.3 years, range 12 days to 8.0 years). Estimated recurrence-free survival rates (95% CI, number of patients still at risk) at 1, 3, and 5 years after surgery were 100% (100%-100%, 16), 74% (53%-100%, 7), and 50% (26%-96%, 4), respectively, for the patients aged 70 years or older and 100% (100%-100%, 17), 73% (51%-100%, 6), and 73% (51%-100%, 2), respectively, for the control cohort (Fig. 2) . No statistically significant difference in tumor recurrence rates was detected between the 2 cohorts (p = 0.38). The median growth rate of the recurrent VS tumor was 4.8 mm/year (range 2.1-14.9 mm/year) in the 6 elderly patients and 2.2 mm/year (range 1.9-4.0 mm/year) in the 3 control patients.
Of the 9 patients with growing lesions following STR, 6 underwent additional intervention (5 SRS and 1 microsurgery) and showed no evidence of tumor progression at the last follow-up (Table 6 ). The remaining 3 patients were advised to undergo additional treatment; however, 1 was scheduled, but had not yet completed SRS, 1 died of disease, and 1 patient refused additional treatment because of serious but unrelated health concerns. In addition to those requiring treatment for growing tumors, 4 patients underwent SRS for asymptomatic residual tumor, and none of these patients showed progression of disease over an average radiological follow-up period of 4.3 years (Table 6) . Concerning overall survival, more deaths occurred in the elderly patient cohort, with 20% (4 of 20) of patients deceased at the time of data collection, than in the younger cohort (0%) (Fig. 3 left) . Two deaths appeared to be unrelated to the diagnosis or treatment of VS: 1 patient died at age 78, 82 months after an intervention for an unknown cause and showed no evidence of recurrent VS prior to death. The second patient died of metastatic breast cancer and pulmonary complications 6 months after intervention. The remaining 2 patients died because of VS treatment-associated factors. These included a patient who died of Clostridium difficile colitis 2 months after surgery and a patient who died following a cystic recurrence 39 months after the initial surgical intervention and who had associated cardiac and respiratory comorbidities (Fig. 4) . No autopsy was performed on the latter patient, but the leading diagnoses for cause of death were hydrocephalus or brainstem compression. Estimated disease-specific survival rates (95% CI, number of patients still at risk) at 1, 3, and 5 years after surgery were 94% (83%-100%, 15), 94% (83%-100%, 9), and 82% (61%-100%, 6), respectively, for the elderly cohort and 100% (100%-100%, 17), 100% (100%-100%, 6), and 100% (100-100%, 2), respectively, for the controls (Fig. 3  right) . Statistical analysis of disease-specific survival was not possible because of the low number of observations. The overall mortality rate was higher in the elderly group than in the younger cohort, but this difference was not statistically significant (p = 0.068) and was multifactorial in nature (Fig. 3 left) .
Discussion
When necessitated by VS tumor growth, tumor size, Fig. 1 for facial nerve function. † Not reported since fewer than 5 patients (cases and controls combined) had the feature listed or lacked this feature. This limited variability did not provide enough statistical power to determine an association between the 2 groups. ‡ Assessed in 39 patients. § The OR represents a 0.1-unit increase. * Diagnosis and treatments of cardiac events were the following: in patients < 70 years, minor elevation in troponins and creatinine, managed conservatively; in patients ≥ 70 years, 1) transient ST-segment elevation in electrocardiogram and associated syncopal event, managed conservatively; 2) hypertension and an associated demand ischemia, treated with medical management; 3) refractory hypertension, ultimately controlled with medical management; 4) episode of atrial flutter, managed conservatively; 5) second-degree heart block, elevated creatine kinase MB, managed conservatively; and 6) transient lateral ischemia, managed conservatively. † Additional surgical interventions associated with a complication were the following: in all patients < 70 years, surgical obliteration or wound revision for CSF leakage; in patients ≥ 70 yrs, 1) external ventricular drain removed on postoperative Day 1, return to the operating room for washout of wound infection, lumbar drain for increased confusion; 2) return to operating room for abdominal fat donor site hematoma. ‡ Leakage of CSF in patients < 70 years: 1) CSF rhinorrhea 12 months after retrosigmoid STR for a 2.35-cm VS, surgical middle ear obliteration, fat graft and external auditory canal closure; 2) immediate postoperative otorhinorrhea after translabyrinthine STR for a 2-cm VS, resolved with lumbar drain; 3) intermittent CSF otorhinorrhea presenting 5 years after a retrosigmoid STR for a 3.6-cm VS, surgical middle ear obliteration, fat graft, and external auditory canal closure; and 4) immediate postoperative CSF otorhinorrhea after a translabyrinthine STR for a 3.6-cm VS, surgical fat graft, and wound revision. § Not reported since fewer than 5 patients (cases and controls combined) had the feature listed or lacked this feature. This limited variability did not provide enough statistical power to determine an association between the 2 groups.
symptoms, or patient preference, surgical intervention is an important option for managing VS in the elderly. However, despite several studies indicating the relative safety of this procedure in older patients, 9, 11 there is a hypothetical increase in the risk of associated complications or poor outcome due to associated comorbidities, decreased functional reserve, and vestibulopathy postoperatively. 1, 7 In addition, the unpredictable growth pattern of these tumors and the decreased life expectancy of these patients makes it challenging to understand the natural history of VS in the elderly. 4 This is underscored when STR is used to minimize associated morbidity. 11 Our goal was to evaluate the risks of surgery associated with age and the behavior of these tumors in the elderly following resection by directly comparing 2 populations of patients differing in age.
Several authors have reported increased complication rates in elderly patients undergoing microsurgical resection for VS.
9,11 Roehm and Gantz identified tumor size, age at surgery, and ASA score to be significantly associated with major complications. 11 Complications were identified in 38.9% of elderly patients in this study, significantly increased from the 8.3% complication rate previously reported by these authors for microsurgical resection. 11 Despite increased ASA scores in our elderly cohort, there were no significant differences in overall complication rates between the 2 groups, suggesting that tumor size and extent of resection may drive complication rates more than age alone. Admittedly, there is an inherent selection bias when patients are initially offered surgical intervention. Oghalai et al. also found a complication rate similar to ours, regardless of age. 8 The most common complications in our study were perioperative cardiac events, which occurred in 30% (6 of 20) of the elderly patients and in 5% (1 of 20) of the younger patients. Cardiac events ranged from minor electrocardiogram changes to atrial flutter and a syncopal episode (Table 3 ). There were no perioperative myocardial infarctions or associated deaths.
Preserving neural function in patients undergoing resection for VS is a critical benchmark. It has been hypothesized that facial nerve preservation in the elderly is complicated by a high incidence of atherosclerosis leading to decreased perfusion via feeding vessels and subsequently to poor regenerative capacity.
7 Both Nusseir et al. and Roehm and Gantz identified tumor size as a critical predictor of facial nerve outcomes, and neither study found age to be directly related to these outcomes, especially when associated with STR. 7, 11 Our data support this hypothesis, as there was no significant difference in House-Brackmann scores at any study time point. We carefully matched the cohort and control groups based on tumor size to try to eliminate this confounding variable. Although preservation of hearing is also associated with surgical morbidity, we found no difference between groups. This may be related to the high number of patients who presented with nonserviceable hearing in each group, and the relatively large average tumor size in our study population. 9 Notably, elderly patients in our study were significantly more likely to have poor balance function both before and after surgery. This resulted in more frequent inpatient rehabilitation and continued rehabilitation efforts, either as an outpatient or intensively as a resident in a rehabilitation facility after the acute postoperative hospitalization. This finding supports the hypothesis that elderly patients have more difficulties compensating postoperatively and may have poorer functional and vestibular reserves than younger patients. 1, 7 It is likely that elderly patients present with comorbidities that directly impact their global balance function, including poorer visual acuity, diminished proprioception or cerebellar function, and a higher incidence of contralateral vestibular hypofunction, 1 resulting in greater sensitivity to any vestibular insult associated with VS or the resection. These comorbidities ultimately prolong recovery and may increase the total cost of microsurgical resection in the elderly population. Understanding these factors in the perioperative care of geriatric patients is important when providing preoperative counseling and planning postoperative care.
Perioperative mortality is relatively uncommon in the elderly population following VS resection. In 1997, Glasscock and colleagues identified a 5% mortality rate, 4 whereas more recently a study by Nusseir et al. reported only 1 perioperative death among 232 patients, suggesting a less than 1% risk. 7 In our study, we noted 4 deaths in the elderly cohort of patients. Two of these deaths were conclusively unrelated to the VS or the resection, and the other 2 deaths were associated with VS treatment and tumor recurrence. The first of these occurred in an elderly patient who contracted Clostridium difficile during his hospitalization after STR of a large cystic, symptomatic VS, and the second death occurred 39 months after the initial surgery in a patient in whom an aggressive cystic VS recurred (Fig. 4) . Because of his associated respiratory and cardiac comorbidities, this latter patient was unable to undergo salvage surgery. The leading hypotheses for this patient's cause of death were hydrocephalus or brainstem compression; however, no autopsy was performed for a definitive diagnosis. Therefore, despite the fact that our study showed a trend toward statistical significance (p = 0.068), the association between death and age is likely multifactorial.
Finally, while GTR remains the gold standard for microsurgical resection of VS, STR should be considered when resecting large, symptomatic VS, especially in elderly patients, in an effort to minimize surgical morbidity. 7 Although it might be possible to extrapolate that a small remnant VS in an elderly patient would allow for de-escalation of postoperative surveillance because of the slow predicted growth rates of the tumor and decreased life expectancy in these patients, it has been our experience that tumor may recur within the lifetime of an elderly patient and that its clinical impact can be devastating. Unlike Nusseir et al., 7 we found a relatively high risk of recurrence following STR in the elderly group. Specifically, in the current study 38% of tumors in 6 of 16 patients recurred after STR in the elderly group compared with 19% of tumors (in 3 of 16 patients) in the younger control group. The latter data are consistent with a previous report in which we found that 6 of 27 tumors (22%) recurred following STR when including all age groups in the analysis. 2 In addition, we found no statistically significant differences in the growth rate of the recurrent tumors between the 2 groups (p = 0.38). When considering the poor functional reserve in the elderly and the potential for rapid growth, we recommend against deescalated postoperative imaging surveillance for these patients. 2 Specifically, for elderly patients, after STR we recommend an initial follow-up MRI scan at 3 months and 1 year postoperatively, and then yearly for at least the next 5 years.
We strongly consider SRS in elderly patients after STR, given the presented evidence that tumor remnants pose a high risk for progression with potentially devastating consequences in this population. In addition, if there is a concern that a patient will be lost to follow-up or if the patient's tumor showed rapid growth before the STR, and assuming the tumor remnant will behave equally aggressively, we consider all patients at high risk, regardless of age. Therefore, these patients are considered early SRS candidates following STR. Conversely, for patients with a House-Brackmann Grade 3 or an increased facial weakness after STR, we prefer to wait at least 1 year before proceeding with follow-up SRS to minimize the risk of exacerbating the facial paresis. 10 Many studies have demonstrated the efficacy of SRS in elderly patients with growing tumors who are not ideal surgical candidates, and the present study supports its use in prophylactically treating tumor remnants following STR in this population. Identifying individuals at high risk for recurrence and monitoring patients with close radiological surveillance can influence management and outcome and, therefore, should be emphasized. We recommend the same imaging surveillance after SRS as outlined above.
This study was limited by the relatively low number of patients included and inherent biases associated with the retrospective nature of data collection and analysis. Again, there was a selection bias in how patients were initially chosen to undergo VS surgery, and the small sizes of the cohorts limited our ability to demonstrate statistically significant differences in many variables. Because of its small sample size and only 9 observed tumor recurrences and 2 disease-specific deaths, the study lacked sufficient statistical power to adequately compare the rate of tumor recurrence and rates of recurrence-free and disease-specific survival between the groups. We attempted to overcome some of these limitations by conducting a matched-cohort analysis.
Conclusions
As the number of elderly patients diagnosed with VS continues to increase, microsurgical resection will remain an important management option for patients presenting with large, symptomatic tumors. Despite a poorer preoperative physical status in elderly patients, their morbidity profiles are similar to those in adult patients younger than 70 years. However, elderly patients may require longer convalescence secondary to prolonged postoperative imbalance. Two disease-specific deaths occurred in the elderly cohort, which may indicate a higher mortality risk associated with VS in these patients. Further study is needed to validate this finding. The risk of tumor recurrence was higher for STR in this study, consistent with the literature. 2 As more elderly patients are offered STR for management of large, symptomatic VS, we recommend against de-escalation of surveillance based on age and recommend consideration of early SRS for the tumor remnant following STR. 
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